Shares of biotech companies and pharmaceutical companies got no traction this week from the $2 billion takeover of Alder Biopharmaceuticals (ALDR) or a "largely symbolic" House plan to slash drug prices.
Biotech company stocks meandered sideways this week, as of Friday's close. At the same time, shares of pharmaceutical companies didn't do much better — riding up about 2% over the course of five days.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,